CLINICAL_TRIALS
trial_result
· 2014-05-20
Clinical Trial Update: PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis [Phase 3]
Summary
Phase 3 trial update for apremilast in active psoriatic arthritis reports efficacy and safety results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-05-20